Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Azeevit is an oral multivitamin and amino acid combination syrup developed and marketed by Obsons Pharmaceuticals. It is formulated with thiamine hydrochloride (vitamin B1), riboflavin (vitamin B2), pyridoxine hydrochloride (vitamin B6), cyanocobalamin (vitamin B12), ascorbic acid (vitamin C), nicotinamide (vitamin B3), calcium pantothenate (vitamin B5), and lysine hydrochloride. This combination is designed to prevent or treat vitamin deficiencies, support metabolic function, promote healthy growth, and improve appetite, particularly in pediatric and geriatric populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Azeevit.